DIVISLAB vs SUNPHARMA vs TORNTPHARM vs LAURUSLABS: which stock is better?
Divi's Laboratories Limited (DIVISLAB) has the highest StockLens rating in this group at 8.0/10 (Excellent).
| Metric | DIVISLAB | SUNPHARMA | TORNTPHARM | LAURUSLABS |
|---|---|---|---|---|
| Overall rating | 8.0/10 (Excellent) | 6.2/10 (Average) | 5.5/10 (Average) | 7.3/10 (Good) |
| Long-term view | Strong long-term candidate | Good for long-term | Neutral (watchlist) | Good for long-term |
| Trade bias | Strong long | Long bias | Long bias | Strong long |
| Share price | ₹11,049.00 | ₹1,871.50 | ₹4,610.70 | ₹2,322.50 |
| Market cap | ₹2,93,316 Cr | ₹4,49,036 Cr | ₹1,75,376 Cr | ₹1,25,488 Cr |
| P/E | 87.2 | 41.0 | 77.9 | 93.7 |
| Return on equity | 20.1% | 13.1% | 15.7% | 24.0% |
| Debt / equity | 0.00 | 0.04 | 0.77 | 0.42 |
| Revenue growth (YoY) | +35.4% | +11.9% | +50.8% | +33.4% |
| 1-year return | +69.0% | +9.1% | +20.5% | +135.6% |
Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.